Sgrna targeting porcine pleg1abc locus, and recombinant expression vector, and preparation method therefor and use thereof

By designing sgRNA and recombinant expression vectors targeting the pLEG1abc locus, using the CRISPR/Cas9 system, the simultaneous deletion of pLEG1a, pLEG1b and pLEG1c genes was successfully achieved, solving the shortcomings of the deletion method in the existing technology, and providing Technical support for research and breeding and demonstrate efficient editing of long fragment genes.

WO2024234997A1PCT designated stage expired Publication Date: 2024-11-21ZHEJIANG UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/090541
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-17
Filing Date
2024-04-29
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

The prior art lacks a method to effectively and accurately delete porcine pLEG1a, pLEG1b and pLEG1c genes, which has affected the functional research of these genes in mammals and the progress of pig breeding.

Method used

Design sgRNA and recombinant expression vectors targeting the pLEG1abc locus, and use gRNA1 and gRNA2 to target the starting point of pLEG1c and pLEG1b, combined with BbsI restriction enzyme and electrotransfection technology to achieve pig fetus Gene editing of fibroblasts, deletion of specified loci.

Benefits of technology

The simultaneous effective deletion of porcine pLEG1a, pLEG1b and pLEG1c genes is achieved, providing a technical basis for studying the functions of these genes and building a deletion model, and demonstrating the efficient editing ability of long fragment genes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024090541_21112024_PF_FP_ABST
    Figure CN2024090541_21112024_PF_FP_ABST
Patent Text Reader

Abstract

Provided are an sgRNA targeting a porcine pLEG1abc locus, and a recombinant expression vector comprising the sgRNA, and a preparation method therefor and the use thereof. On the basis of the recombinant expression vector, also provided are a porcine fetal fibroblast in which the porcine pLEG1abc locus is deleted, and a preparation method therefor. The three genes, i.e. pLEG1a, pLEG1b and pLEG1c, on the same chromosome of a pig can be effectively and accurately deleted at the same time, so as to obtain a porcine fetal fibroblast in which a liver-enriched gene 1 is deleted, thereby providing a technical basis for subsequent construction of an experimental porcine model with pLEG1 deletion. In addition, on the basis of a CRISPR / Cas9 system, an sgRNA targeting a long-fragment gene of at least 80,000 bp is designed according to the sgRNA target site, and the long-fragment gene is successfully deleted, so that the efficient deletion of a long-fragment gene on the basis of a CRISPR / Cas9 system is realized.
Need to check novelty before this filing date? Find Prior Art

Description

An sgRNA targeting the porcine pLEG1abc locus, a recombinant expression vector, and its preparation method and application Technical Field

[0001] The present invention relates to the field of animal genetic engineering technology, and in particular to an sgRNA targeting the porcine pLEG1abc locus, a recombinant expression vector containing the sgRNA, and a preparation method and application thereof. Background Art

[0002] Liver-enriched gene 1 (LEG1) is evolutionarily conserved among vertebrates and encodes a novel glycosylated secretory protein, LEG1. In pigs, three copies of LEG1 have been found—pLEG1a, pLEG1b, and pLEG1c. The pLEG1a and pLEG1b proteins are structurally similar to zebrafish liver-enriched gene 1 (zLEG1), mouse liver-enriched gene 1 (mLEG1), and human liver-enriched gene 1 (hLEG1), all containing signal peptides and specific domains. However, pLEG1c lacks a signal peptide and contains only the LEG1 domain.

[0003] Currently, the function of LEG1 in mammals remains unclear. However, miniature pigs, due to their similarity to humans, have become one of the most important experimental species, widely used in disease model studies and xenotransplantation research. Therefore, to further investigate the function of this gene in mammals, it is necessary to establish a method for efficiently, accurately, and effectively deleting pLEG1 and to generate pig fibroblasts in which the liver-enriched gene 1 is deleted. This is of great significance for studying the function of this gene in mammals and for pig breeding.

[0004] Summary of the Invention

[0005] The purpose of the present invention is to solve the problem in the prior art of lacking a method for simultaneously and effectively and accurately deleting the three genes of pig pLEG1a, pLEG1b and pLEG1c, and to provide an sgRNA targeting the pig pLEG1abc locus, a recombinant expression vector, and a preparation method and application thereof.

[0006] To solve the above technical problems, the technical solution adopted by the present invention is as follows: an sgRNA targeting the pig pLEG1abc locus, in which three gene copies of pLEG1c, pLEG1a and pLEG1b in the pig pLEG1abc locus are connected in series, and the sgRNA includes gRNA1 and gRNA2, the gRNA1 targets the sequence at the start of pLEG1c, and the nucleotide sequence of the gRNA1 is shown in SEQ ID No.1; the gRNA2 targets the sequence at the start of pLEG1b, and the nucleotide sequence of the gRNA2 is shown in SEQ ID No.2.

[0007] The present invention provides a recombinant expression vector comprising the above-mentioned sgRNA.

[0008] Preferably, the method for constructing the recombinant expression vector comprises the following steps:

[0009] S1. The primers for gRNA1 are gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1, and the primers for gRNA2 are gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2; the nucleotide sequences of gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1 are shown in SEQ ID No.3 and SEQ ID No.4, respectively; the nucleotide sequences of gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2 are shown in SEQ ID No.5 and SEQ ID No.6, respectively;

[0010] S2. Linearize the gRNA cloning vector pX459 containing the U6 promoter driven by BbsI restriction enzyme to obtain a linearized pX459 vector;

[0011] S3. gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1, gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2 were denatured, annealed and connected into the linearized pX459 vector, respectively, to construct recombinant expression vectors pX459-gRNA-1 vector and pX459-gRNA-2 vector.

[0012] The present invention also provides a method for preparing porcine fetal fibroblasts with the pLEG1abc locus deleted, comprising constructing the above-mentioned recombinant expression vector, transferring the recombinant expression vector into porcine fetal fibroblasts by electrofection, screening the cells using puromycin antibiotics and a monoclonal limiting dilution method, and identifying the screened cell clones by PCR. The obtained positive cell clones are porcine fetal fibroblasts with the porcine pLEG1abc locus deleted, wherein the deletion of the porcine pLEG1abc locus involves the simultaneous deletion of the three genes, pLEG1a, pLEG1b, and pLEG1c, on the same chromosome.

[0013] Preferably, primers KO-Primer-F and KO-Primer-R, and primers WT-Primer-F and WT-Primer-R are used to perform PCR amplification detection on the screened cell clone points, and the positive cell clone points are identified based on the PCR amplification results; the nucleotide sequences of the primers KO-Primer-F and KO-Primer-R are shown in SEQ ID No.7 and SEQ ID No.8; the nucleotide sequences of the primers WT-Primer-F and WT-Primer-R are shown in SEQ ID No.9 and SEQ ID No.10.

[0014] The present invention also provides pig fetal fibroblasts deleted of the pig pLEG1abc gene locus, which are prepared according to the above preparation method.

[0015] Preferably, at least 4 genotypes are pLEG1 delabc / + The nucleotide sequences of the four positive cell cloning points are shown in SEQ ID No.11 to SEQ ID No.14 respectively.

[0016] The present invention also provides the use of the recombinant expression vector in preparing a gene deletion experimental pig model.

[0017] The beneficial effects of the present invention are:

[0018] (1) The present invention can effectively and accurately delete the three genes of pig pLEG1a, pLEG1b and pLEG1c at the same time, obtain pig fetal fibroblasts with deleted liver-enriched gene 1, and provide a technical basis for the subsequent construction of an experimental pig model lacking pLEG1;

[0019] (2) The present invention is based on the CRISPR / Cas9 system and is designed to target at least 80,000 bp of a long gene (three gene copies of pig pLEG1a, pLEG1b and pLEG1c) according to the sgRNA target site. It successfully deletes the long gene site and realizes the efficient deletion of long genes based on the CRISPR / Cas9 system, which has important guiding significance for the establishment of various animal models. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] FIG1 is a diagram showing the construction of the recombinant expression vector in Example 1;

[0021] Figure 2 is a schematic diagram of the pLEG1 gene and a schematic diagram of the positions of the KO-Primer-F / R and WT-Primer-F / R primers in Example 3;

[0022] FIG3 is the genotype identification results of some cell clones in Example 3;

[0023] FIG4 is a schematic diagram of the pLEG1abc long fragment gene deletion at four positive cell clones in Example 3;

[0024] FIG5 shows the cell confluence status of four positive cell clones before freezing in Example 3;

[0025] FIG6 is a diagram of the reconstructed embryo in Example 4;

[0026] FIG7 is a diagram showing the genotype identification results of the two aborted embryos in Example 4. DETAILED DESCRIPTION

[0027] The present invention will be further described below with reference to the accompanying drawings and specific embodiments.

[0028] Vector pX459 was purchased from Addgene (Plasmid #62988; Watertown, MA, USA); 32-day-old male Chinese experimental miniature pig embryos were purchased from the Zhuozhou Miniature Pig Experimental Base of China Agricultural University; wild-type pLEG1 locus sequences (pLEG1a: XM_003121211.1, pLEG1b: XM_021074892.1, pLEG1c: XM_021084485.1).

[0029] Example 1 Construction of recombinant expression vectors pX459-gRNA-1 and pX459-gRNA-2

[0030] 1. Using an online gRNA design tool (http: / / crispr.dfci.harvard.edu / SSC / ), gRNAs targeting both ends of the porcine pLEG1abc locus were designed, including gRNA1 and gRNA2. The nucleotide sequence of gRNA1 is shown in SEQ ID No. 1, targeting the 5'-TTAAAGATCCATTTCACTAG-3' sequence at the beginning of pLEG1c; the nucleotide sequence of gRNA2 is shown in SEQ ID No. 2, targeting the 5'-GTTCTCTCCTGGCTAATGAT-3' sequence at the beginning of pLEG1b.

[0031] 2. Based on the sequences of gRNA1 and gRNA2, the primers for gRNA1 were designed as gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1, as shown in SEQ ID No.3 and SEQ ID No.4, respectively; the primers for gRNA2 were designed as gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2, as shown in SEQ ID No.5 and SEQ ID No.6, respectively.

[0032] 3. Use BbsI restriction endonuclease to linearize the gRNA cloning vector pX459 driven by the U6 promoter to obtain a linearized pX459 vector.

[0033] 4. Primers gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1, gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2 were denatured, annealed and ligated into the linearized pX459 vector to construct recombinant expression vectors pX459-gRNA-1 vector and pX459-gRNA-2 vector, respectively. The recombinant expression vector construction map is shown in Figure 1.

[0034] Example 2 Culture, transfection and screening of porcine fetal fibroblasts with deleted porcine pLEG1abc locus

[0035] Porcine fetal fibroblasts (PFFs) were isolated from 32-day-old male Chinese laboratory miniature pig embryos. These primary cells were cultured in high-glucose Dulbecco's Medium Eagle's medium (Gibco, Gaithersburg, DMEM, USA) supplemented with 20% fetal bovine serum (FBS, Gibco).

[0036] All animal experiments were performed according to the guidelines established by the Chinese Animal Care and Protocol Committee and approved by the Laboratory Animal Welfare Committee of Zhejiang University (Zhejiang Province, China).

[0037] PFFs were transfected with 2.5 μg of pX459-gRNA-1 (prepared in Example 1) and 2.5 μg of pX459-gRNA-2 (prepared in Example 1) using a Lonza 4D-Nucleofector. The PFFs were thawed and cultured one day before transfection. Transfection was then performed using 82 μL of PS solution and 18 μL of supplement at DO-113 parameters, with approximately 1×10 6 PFFs cells. Since both pX459-gRNA-1 and pX459-gRNA-2 vectors carry Puro R Resistance gene, so subsequent screening uses puromycin antibiotics. 24 hours after transfection, cell screening is performed using the monoclonal limiting dilution method: cells are plated in 96-well plates at 50 cells / well. After 24 hours, the cells are cultured in DMEM containing 2μg / mL puromycin and 20% FBS for 3 days, and then replaced with DMEM medium containing 20% ​​FBS without puromycin until single cell clones grow. Single cell clones are then selected and cultured in 24-well plates. When clones appear in the 24-well plate, they are digested and transferred to a 6-well plate for continued culture. The remaining small amount of cells continues to grow in the 24-well plate, and genome extraction is subsequently performed to identify mutations. When the cells transferred to the 6-well plate reach confluence, they are frozen and stored for subsequent somatic cell nuclear transplantation operations.

[0038] Example 3 Identification of porcine fetal fibroblasts with deleted porcine pLEG1abc locus

[0039] Genomic DNA was extracted from the cell clones screened in Example 2 using a Genomic DNA Purification Kit (EZBioscoence), and PCR was then performed using a high-fidelity polymerase (Thermo Fisher Scientific). The primers used for PCR amplification were KO-Primer-F and KO-Primer-R (nucleotide sequences shown in SEQ ID No. 7 and SEQ ID No. 8), and WT-Primer-F and WT-Primer-R (nucleotide sequences shown in SEQ ID No. 9 and SEQ ID No. 10). KO-Primer-F / R is located on both sides of the gRNA1 and gRNA2 sites designed in Example 1, with the long pLEG1 gene fragment in the middle; WT-Primer-F / R is a primer designed based on a fragment of approximately 500 bp on the pLEG1 gene.

[0040] If the long pLEG1 gene fragment is not deleted, the KO-Primer-F / R primers cannot fully amplify the template due to their large amplification span, resulting in no specific band. However, the WT-Primer-F / R primers can amplify a specific band of approximately 500 bp. If the long pLEG1 gene fragment is deleted, the KO-Primer-F / R primers can amplify a specific band of approximately 500 bp, while the WT-Primer-F / R primers do not. A schematic diagram of the pLEG1 gene and the positions of the KO-Primer-F / R and WT-Primer-F / R primers are shown in Figure 2.

[0041] As shown in Figure 3, since the positive cell clones exist in both homozygous and heterozygous situations, if they are homozygous, a band of approximately 500 bp is observed when PCR amplification is performed using KO-Primer-F / R, while no band is observed when PCR amplification is performed using primers WT-Primer-F / R. If the positive cell clones are heterozygous (as shown in lanes 3 and 12 in Figure 3), a band of approximately 500 bp appears when PCR amplification is performed using both KO-Primer-F / R and WT-Primer-F / R primers.

[0042] In this example, pure water was used as a negative control, and PCR was performed to identify the 179 cell clones screened in Example 2. It was identified that 27 of these 179 clones were positive, i.e., correct long fragment deletion clones, with a genotype of pLEG1. delabc / + , the deletion rate was 15.08%. Among the 27 positive cell clones, 4 clones grew rapidly and were in good condition, and were sequenced. The nucleotide sequences of these 4 positive cell clones were sequenced as shown in SEQ ID No.11-SEQ ID No.14, and the schematic diagram of the deletion of the pLEG1abc long fragment gene in these 4 positive cell clones is shown in Figure 4. The cell confluence status of the 4 positive cell clones before freezing is shown in Figure 5. The sequencing results show that this example successfully obtained pig fetal fibroblasts with the correct deletion of the pLEG1abc long fragment gene.

[0043] Example 4 Somatic Cell Nuclear Transfer of Porcine Fetal Fibroblasts Deleting the Porcine pLEG1abc Gene

[0044] The cells frozen in Example 2 were subjected to somatic cell nuclear transplantation, and a total of 1350 reconstructed embryos were obtained with a cleavage rate of 97%, as shown in Figure 6. Five sows were transplanted with embryos, one of which was pregnant, and two aborted embryos were obtained through active abortion and genotype identification (genotype identification method was consistent with Example 3). After identification, it was found that one of the embryos was wild type, and the other embryo was a pLEG1abc gene deletion heterozygote. The genotype identification results of the two aborted embryos are shown in Figure 7, where #1, #2, #3, and #4 are respectively the aborted embryo tissue block numbers, and wherein #1 and #2 are from the same embryo, and #3 and #4 are from another embryo.

[0045] The description and drawings of the present invention are considered to be illustrative rather than restrictive. On the basis of the present invention, those skilled in the art can make some substitutions and modifications to some of the technical features according to the disclosed technical content without creative work, and all of them are within the scope of protection of the present invention.

Claims

1. A sgRNA targeting the porcine pLEG1abc locus, characterized in that: The three gene copies of pLEG1c, pLEG1a and pLEG1b in the pig pLEG1abc locus are connected in series in sequence, and the sgRNA includes gRNA1 and gRNA2. The gRNA1 targets the sequence at the beginning of pLEG1c, and the nucleotide sequence of the gRNA1 is shown in SEQ ID No.1; the gRNA2 targets the sequence at the beginning of pLEG1b, and the nucleotide sequence of the gRNA2 is shown in SEQ ID No.

2.

2. A recombinant expression vector, characterized in that: The recombinant expression vector comprises the sgRNA according to claim 1.

3. The recombinant expression vector according to claim 2, characterized in that The method for constructing the recombinant expression vector comprises the following steps: S1. The primers for gRNA1 are designed to be gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1, and the primers for gRNA2 are designed to be gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2; the nucleotide sequences of gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1 are shown in SEQ ID No.3 and SEQ ID No.4, respectively; the nucleotide sequences of gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2 are shown in SEQ ID No.5 and SEQ ID No.6, respectively; S2. Linearize the gRNA cloning vector pX459 driven by the U6 promoter using the BbsI restriction endonuclease to obtain a linearized pX459 vector; S3. Denature and anneal gDNA-pLEG1s-F1 and gDNA-pLEG1s-R1, gDNA-pLEG1s-F2 and gDNA-pLEG1s-R2 and connect them into the linearized pX459 vector to construct recombinant expression vectors pX459-gRNA-1 vector and pX459-gRNA-2 vector, respectively.

4. A method for preparing porcine fetal fibroblasts with porcine pLEG1abc locus deleted, characterized in that: Construct the recombinant expression vector as described in claim 3, transfer the recombinant expression vector into porcine fetal fibroblasts by electrofection, perform cell screening by puromycin antibiotics and monoclonal limiting dilution method, perform PCR identification on the screened cell clone points, and the obtained positive cell clone points are porcine fetal fibroblasts with the porcine pLEG1abc locus deleted, wherein the deletion of the porcine pLEG1abc locus is to simultaneously delete the three genes of porcine pLEG1a, pLEG1b and pLEG1c on the same chromosome.

5. The preparation method according to claim 4, characterized in that: Primers KO-Primer-F and KO-Primer-R, and primers WT-Primer-F and WT-Primer-R are used to perform PCR amplification detection on the screened cell clone points, and the positive cell clone points are identified according to the PCR amplification results; the nucleotide sequences of the primers KO-Primer-F and KO-Primer-R are shown in SEQ ID No.7 and SEQ ID No.8; the nucleotide sequences of the primers WT-Primer-F and WT-Primer-R are shown in SEQ ID No.9 and SEQ IDNo.

10. 6 . The porcine fetal fibroblasts deleted of the porcine pLEG1abc locus prepared by the preparation method according to claim 5 .

7. The porcine fetal fibroblasts with porcine pLEG1abc locus deleted according to claim 6, characterized in that: At least 4 genotypes were included for pLEG1 delabc / + positive cell cloning points, and the nucleotide sequences of the four positive cell cloning points are shown in SEQ ID No.11-SEQ ID No.14 respectively.

8. Use of the recombinant expression vector according to claim 2 in preparing a gene deletion experimental pig model.

Citation Information

Patent Citations

  • HLeg1 protein, applications thereof and drugs

    CN106883294A

  • HLeg1 gene and application and drug thereof

    CN106929511A

  • Efficient gene knockout vector and application thereof

    CN111172191A

  • SgRNA targeting pig pLEG1abc gene locus, recombinant expression vector, and preparation method and application of sgRNA

    CN116769775A

  • Leg1 protein, leg1 gene, applications of leg1 protein and leg1 gene, and drug

    WO2018120610A1